UK clinical trial regulations reform 2026
The Medicines for Human Use (Clinical Trials) (Amendment) Regulations 2025 (SI 2025/538) came into force on 28 April...
Categories
Connect with us on LinkedIn
Implications of Assessing Overall Survival in Oncology Studies
The FDA’s August 2025 draft guidance reshapes oncology clinical trials by requiring pre-specified overall survival (OS) analysis in...
Automated Evidence Generation for Regulatory-Grade Real-World Data
Manual data abstraction can’t keep up with new FDA and EMA RWE standards. This whitepaper explains how automated...
The EMR Interoperability Dream vs. Clinical Research Reality
A Practical Guide to the 21st Century Cures Act, FHIR Data, and Bridging the Gap for Audit-Ready Evidence
Discover the real-world challenges of EMR interoperability in clinical research. Learn how the 21st Century Cures Act, FHIR...
ICH GCP E6(R3) Implementation: Practical Approaches and Real-World Considerations
ICH GCP E6(R3) implementation requires strategic planning beyond basic compliance. This practical guide covers realistic 12-18 month timelines,...
